Literature DB >> 22278241

HLA B*5701-positive long-term nonprogressors/elite controllers are not distinguished from progressors by the clonal composition of HIV-specific CD8+ T cells.

Daniel Mendoza1, Cassandra Royce, Laura E Ruff, David R Ambrozak, Máire F Quigley, Thurston Dang, Vanessa Venturi, David A Price, Daniel C Douek, Stephen A Migueles, Mark Connors.   

Abstract

To better understand the qualitative features of effective human immunodeficiency virus (HIV)-specific immunity, we examined the TCR clonal composition of CD8(+) T cells recognizing conserved HIV p24-derived epitopes in HLA-B*5701-positive long-term nonprogressors/elite controllers (LTNP/EC) and HLA-matched progressors. Both groups displayed oligoclonal HLA-B5701-restricted p24-specific CD8(+) T-cell responses with similar levels of diversity and few public clonotypes. Thus, HIV-specific CD8(+) T-cell responses in LTNP/EC are not differentiated from those of progressors on the basis of clonal diversity or TCR sharing.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22278241      PMCID: PMC3302536          DOI: 10.1128/JVI.06982-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  A novel approach to the analysis of specificity, clonality, and frequency of HIV-specific T cell responses reveals a potential mechanism for control of viral escape.

Authors:  Daniel C Douek; Michael R Betts; Jason M Brenchley; Brenna J Hill; David R Ambrozak; Ka-Leung Ngai; Nitin J Karandikar; Joseph P Casazza; Richard A Koup
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

2.  HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors.

Authors:  Stephen A Migueles; Alisha C Laborico; W Lesley Shupert; M Shirin Sabbaghian; Ronald Rabin; Claire W Hallahan; Debbie Van Baarle; Stefan Kostense; Frank Miedema; Mary McLaughlin; Linda Ehler; Julia Metcalf; Shuying Liu; Mark Connors
Journal:  Nat Immunol       Date:  2002-10-07       Impact factor: 25.606

3.  Escape from highly effective public CD8+ T-cell clonotypes by HIV.

Authors:  Maria Candela Iglesias; Jorge R Almeida; Solène Fastenackels; David J van Bockel; Masao Hashimoto; Vanessa Venturi; Emma Gostick; Alejandra Urrutia; Linda Wooldridge; Mathew Clement; Stéphanie Gras; Pascal G Wilmann; Brigitte Autran; Arnaud Moris; Jamie Rossjohn; Miles P Davenport; Masafumi Takiguchi; Christian Brander; Daniel C Douek; Anthony D Kelleher; David A Price; Victor Appay
Journal:  Blood       Date:  2011-07-06       Impact factor: 22.113

4.  Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity.

Authors:  P O Flores-Villanueva; E J Yunis; J C Delgado; E Vittinghoff; S Buchbinder; J Y Leung; A M Uglialoro; O P Clavijo; E S Rosenberg; S A Kalams; J D Braun; S L Boswell; B D Walker; A E Goldfeld
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

5.  Comparison between HIV- and CMV-specific T cell responses in long-term HIV infected donors.

Authors:  L Papagno; V Appay; J Sutton; T Rostron; G M A Gillespie; G S Ogg; A King; A T Makadzanhge; A Waters; C Balotta; A Vyakarnam; P J Easterbrook; S L Rowland-Jones
Journal:  Clin Exp Immunol       Date:  2002-12       Impact factor: 4.330

6.  HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors.

Authors:  S A Migueles; M S Sabbaghian; W L Shupert; M P Bettinotti; F M Marincola; L Martino; C W Hallahan; S M Selig; D Schwartz; J Sullivan; M Connors
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

7.  The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences.

Authors:  Stephen A Migueles; Alisha C Laborico; Hiromi Imamichi; W Lesley Shupert; Cassandra Royce; Mary McLaughlin; Linda Ehler; Julia Metcalf; Shuying Liu; Claire W Hallahan; Mark Connors
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

8.  Distribution and functional analysis of memory antiviral CD8 T cell responses in HIV-1 and cytomegalovirus infections.

Authors:  Kim Ellefsen; Alexandre Harari; Patrick Champagne; Pierre-Alexandre Bart; Rafick-Pierre Sékaly; Giuseppe Pantaleo
Journal:  Eur J Immunol       Date:  2002-12       Impact factor: 5.532

9.  Greater CD8+ TCR heterogeneity and functional flexibility in HIV-2 compared to HIV-1 infection.

Authors:  A Ross Lopes; Assan Jaye; Lucy Dorrell; Sehu Sabally; Abraham Alabi; Nicola A Jones; Darren R Flower; Anne De Groot; Phillipa Newton; R Monica Lascar; Ian Williams; Hilton Whittle; Antonio Bertoletti; Persephone Borrow; Mala K Maini
Journal:  J Immunol       Date:  2003-07-01       Impact factor: 5.422

10.  Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire.

Authors:  S A Kalams; R P Johnson; A K Trocha; M J Dynan; H S Ngo; R T D'Aquila; J T Kurnick; B D Walker
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

View more
  20 in total

1.  Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulation.

Authors:  Francesco Marras; Elena Nicco; Federica Bozzano; Antonio Di Biagio; Chiara Dentone; Emanuele Pontali; Silvia Boni; Maurizio Setti; Giancarlo Orofino; Eugenio Mantia; Valentina Bartolacci; Francesca Bisio; Agostino Riva; Roberto Biassoni; Lorenzo Moretta; Andrea De Maria
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-01       Impact factor: 11.205

Review 2.  Success and failure of the cellular immune response against HIV-1.

Authors:  Stephen A Migueles; Mark Connors
Journal:  Nat Immunol       Date:  2015-06       Impact factor: 25.606

3.  Complex T-cell receptor repertoire dynamics underlie the CD8+ T-cell response to HIV-1.

Authors:  Ana I Costa; Dan Koning; Kristin Ladell; James E McLaren; Bart P X Grady; Ingrid M M Schellens; Petra van Ham; Monique Nijhuis; José A M Borghans; Can Keşmir; David A Price; Debbie van Baarle
Journal:  J Virol       Date:  2014-10-15       Impact factor: 5.103

4.  Vertical T cell immunodominance and epitope entropy determine HIV-1 escape.

Authors:  Michael K P Liu; Natalie Hawkins; Adam J Ritchie; Vitaly V Ganusov; Victoria Whale; Simon Brackenridge; Hui Li; Jeffrey W Pavlicek; Fangping Cai; Melissa Rose-Abrahams; Florette Treurnicht; Peter Hraber; Catherine Riou; Clive Gray; Guido Ferrari; Rachel Tanner; Li-Hua Ping; Jeffrey A Anderson; Ronald Swanstrom; Myron Cohen; Salim S Abdool Karim; Barton Haynes; Persephone Borrow; Alan S Perelson; George M Shaw; Beatrice H Hahn; Carolyn Williamson; Bette T Korber; Feng Gao; Steve Self; Andrew McMichael; Nilu Goonetilleke
Journal:  J Clin Invest       Date:  2012-12-10       Impact factor: 14.808

5.  Correlates of protective cellular immunity revealed by analysis of population-level immune escape pathways in HIV-1.

Authors:  Jonathan M Carlson; Chanson J Brumme; Eric Martin; Jennifer Listgarten; Mark A Brockman; Anh Q Le; Celia K S Chui; Laura A Cotton; David J H F Knapp; Sharon A Riddler; Richard Haubrich; George Nelson; Nico Pfeifer; Charles E Deziel; David Heckerman; Richard Apps; Mary Carrington; Simon Mallal; P Richard Harrigan; Mina John; Zabrina L Brumme
Journal:  J Virol       Date:  2012-10-10       Impact factor: 5.103

6.  T-Cell Receptor (TCR) Clonotype-Specific Differences in Inhibitory Activity of HIV-1 Cytotoxic T-Cell Clones Is Not Mediated by TCR Alone.

Authors:  Nina C Flerin; Huabiao Chen; Tynisha D Glover; Pedro A Lamothe; Jian Hua Zheng; Justin W Fang; Zaza M Ndhlovu; Evan W Newell; Mark M Davis; Bruce D Walker; Harris Goldstein
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

7.  Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller.

Authors:  Natalia T Freund; Haoqing Wang; Louise Scharf; Lilian Nogueira; Joshua A Horwitz; Yotam Bar-On; Jovana Golijanin; Stuart A Sievers; Devin Sok; Hui Cai; Julio C Cesar Lorenzi; Ariel Halper-Stromberg; Ildiko Toth; Alicja Piechocka-Trocha; Harry B Gristick; Marit J van Gils; Rogier W Sanders; Lai-Xi Wang; Michael S Seaman; Dennis R Burton; Anna Gazumyan; Bruce D Walker; Anthony P West; Pamela J Bjorkman; Michel C Nussenzweig
Journal:  Sci Transl Med       Date:  2017-01-18       Impact factor: 17.956

8.  Combination of immune and viral factors distinguishes low-risk versus high-risk HIV-1 disease progression in HLA-B*5701 subjects.

Authors:  Melissa M Norström; Marcus Buggert; Johanna Tauriainen; Wendy Hartogensis; Mattia C Prosperi; Mark A Wallet; Frederick M Hecht; Marco Salemi; Annika C Karlsson
Journal:  J Virol       Date:  2012-07-03       Impact factor: 5.103

9.  TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection.

Authors:  Huabiao Chen; Zaza M Ndhlovu; Dongfang Liu; Lindsay C Porter; Justin W Fang; Sam Darko; Mark A Brockman; Toshiyuki Miura; Zabrina L Brumme; Arne Schneidewind; Alicja Piechocka-Trocha; Kevin T Cesa; Jennifer Sela; Thai D Cung; Ildiko Toth; Florencia Pereyra; Xu G Yu; Daniel C Douek; Daniel E Kaufmann; Todd M Allen; Bruce D Walker
Journal:  Nat Immunol       Date:  2012-06-10       Impact factor: 25.606

10.  Differential escape patterns within the dominant HLA-B*57:03-restricted HIV Gag epitope reflect distinct clade-specific functional constraints.

Authors:  R P Payne; S Branch; H Kløverpris; P C Matthews; C K Koofhethile; T Strong; E Adland; E Leitman; J Frater; T Ndung'u; E Hunter; R Haubrich; B Mothe; A Edwards; L Riddell; F Chen; P R Harrigan; Z L Brumme; S Mallal; M John; J P Jooste; R Shapiro; S G Deeks; B D Walker; C Brander; C Landis; J M Carlson; J G Prado; P J R Goulder
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.